, , ,

Verify’s Advanced Language Capabilities Offer a Comprehensive, All-in-One Multi-Language Inspection Solution for Global Brands

Date: June, 2024 | Category: proofreading | Author: Hana Trokic

With global brands constantly expanding their reach into new markets, the ability to communicate accurately and effectively across different languages while remaining compliant is not just a competitive advantage—it’s a necessity. 

Verify’s Advanced Language Inspection Capabilities provide global brands with an all-in-one cloud-based solution—powered by AI. Instead of dealing with disjointed proofreading processes for individual languages, this suite of language inspection tools offers a centralized and comprehensive solution for multilingual proofreading. 

Verify’s Advanced Language Inspection Capabilities empower brands to optimize multilingual document inspections through:

  • Spell Check in 42 Languages
  • Text Compare in all Global Languages
  • Automatic Right-to-Left (RTL) Language Compare
  • Automatic Asian Language Compare 
  • Braille Inspection in 44 Languages

Multilingual Spell Check Capabilities

With Spell Check in 42 global languages, along with Medical and Custom Dictionaries, Verify ensures the accuracy of multilingual content and brand-specific terminology. 

These regularly updated dictionaries ensure compliance of critical content with local regulations by preventing spelling errors. 

Text Compare in All Global Languages 

Text Compare, which is available in all global languages, detects all discrepancies in text by comparing documents character-by-character within a matter of seconds. 

This capability safeguards brands from non-intended changes occurring on documents and final packaging assets. 

“[Text compare] is particularly beneficial when working on files in foreign languages. As iNova distributes products to markets globally, quality teams must work on files in languages and alphabets that are not native to them.”

– Phil Sami, Group Operations Improvement Director, iNova Pharmaceuticals

Automatic Right-to-Left Language Compare  

Right-to-left languages such as Arabic and Hebrew are challenging to proofread, especially for non-native readers. Automatic Right-to-Left Language Compare automatically determines text direction on documents and compares text accordingly. 

Automatic Asian Language Compare

Asian languages such as Chinese, Japanese, and Korean, are also challenging for proofreaders. Automatic Asian Language Compare automatically detects Asian characters and allows brands to compare documents with ease. 

“A 4-language leaflet could take upwards of 2 days to manually proofread, a 30-language IFU could take over a week. A 200-page user manual in 30 languages could take months. Using technology can cut that to 15 minutes or so.” 

– William Bosley, Manager Global Labeling and Graphics, Gilead Sciences 

These features increase operational efficiency by reducing the need to outsource, and accelerates time-to-market, especially for relevant Asia-Pacific and Middle Eastern markets. 

Braille Inspection in 44 Languages 

Braille is a mandatory component of pharmaceutical packaging across Europe and ensuring braille accuracy is a crucial part of the pharma document review process. 

With Verify’s Braille Inspection, brands can translate braille in 44 languages and inspect braille regions to ensure compliance with the Marburg Medium Braille Font Standard. This helps avoid non-compliance issues while accelerating EU market penetration and supporting consumer accessibility.

Leverage Verify’s Advanced Language Inspection Capabilities and Foster a Competitive Advantage 

Brands that leverage Verify‘s Advanced Language Inspection capabilities support their global distribution and expansion strategies and uphold their commitment to quality and compliance in an increasingly competitive global landscape. 

Without the need for multiple, complicated tools and resources, brands can centralize multilingual proofreading while: 

  • Enhancing market penetration 
  • Protecting brand reputation
  • Streamlining operations
  • Assuring compliance 
  • Gaining a competitive advantage

/by
, ,

Biogen Optimizes Artwork Development with GlobalVision, Saving $1.2 Million Annually

Date: May, 2024 | Category: Customers | Author: Hana Trokic

Biogen is a leading multinational biotechnology company specializing in therapeutics and medicines for the treatment of neurological diseases, specialized immunology, and rare diseases. Pioneering innovative science to deliver new medicines that transform patient lives, Biogen operates internationally with offices across the Americas, Europe, and Asia.

Challenge: Product Lifecycle Delays Causing Financial Losses

Prior to implementing GlobalVision, Biogen struggled with certain convoluted business processes and unreliable legacy systems that caused delays in their products’ lifecycles. The processes in place made making even minor changes a difficult task.

Their legacy systems were inefficient, resulting in regular compliance issues and data losses, hindering Biogen’s ability to maintain regulatory compliance, and reducing operational efficiency.

Solution: Streamline Artwork Development With Automated Quality Inspections 

In March 2019, Biogen implemented GlobalVision’s suite of automated quality inspection tools in hopes of alleviating these critical delays. The system helped them deliver artwork files exactly as intended and significantly reduced revision cycles. They calculated the following success metrics:

“The Artwork Design Team, Regulatory Teams, Quality Partners, and Graphic Service Providers—across all four of those functions – the time savings are associated with the move to GlobalVision.” 

– Richard Eyre, Associate Director of Product Lifecycle Management Regulatory CMC and Asset Development Project Management IT Systems

Ultimately, Biogen’s implementation of GlobalVision’s market-leading software allowed them to deliver critical medicines to market faster, further solidifying the software’s position as the leading proofreading and quality inspection solution for regulated industries.The software’s capabilities such as pixel-to-pixel comparison and text comparison, quickly proved to be crucial for maintaining the integrity of product information across the product lifecycle.

“The reliability associated with both the implementation, the maintenance, and the operation of  the [GlobalVision] system has been amazing and really is one of the keys to why we want to prolong the relationship with GlobalVision.”

– Richard Eyre, Associate Director of Product Lifecycle Management Regulatory CMC and Asset Development Project Management IT Systems

Join industry leaders and take the first step towards streamlining your artwork development and quality inspection processes today.

/by
,

Drupa 2024: 4 Key Learnings from Week 2

Date: June, 2024 | Category: Company | Author: Myka Luchuk

After a whirlwind few weeks at Drupa, exhibitors and attendees can breathe a sigh of relief thanks to a successful show, full of new leads and fresh insights. With teams returning to their regularly scheduled routines, it’s important to reflect on key learnings and put them into practice moving forward.

Here are 4 of our key takeaways from Drupa 2024:

Automated Inspection Solutions Aren’t Just a “Nice to Have”; They’re a Necessity 

Our team discovered early on that a driving motivation for many attendees was to find ways to make their print and packaging journeys more efficient. Automated inspections play a huge role in aiding print and packaging companies by taking away the need for manual inspections, eliminating costly errors, and getting to market faster than ever. 

At Drupa, we showcased our integrated automations through our partnership with Esko. Esko Automation Engine and Esko WebCenter help to bridge the gap for efficiency in the artwork management system through automated text and graphics compare tools, automated barcode and braille inspection tools, spell check in 37 global languages, and the ability to review annotations directly from the Esko WebCenter.

Customer Feedback Should Drive Product Development

We met with many of our current customers, as well as many new prospective clients at Drupa 2024. What we learned is that our current customers have been very happy with our ability to solve their current inspection needs, but as companies look to scale up, their needs expand. 

From this, we have taken note of what will make our products better, and more applicable to our customers. Some of these requests have included plate inspection, UV print inspection, inline PDF spot checking, crease/fold measurement, and more. 

This is the most valuable feedback to receive, as it ensures that our customers remain happy and that our products continue to be industry-leading. 

The Value of Networking Opportunities 

With attendees from around the world, it’s easy to get excited about the potential for new customers. However, Drupa is not only a prime event to generate fresh leads, it’s also a prime networking event with thousands of industry professionals attending from all over the globe. Some of the best insights, feedback, and conversations happened through intentional conversations with leaders in the print and packaging industry – a valuable asset for advancing our processes into the future.  

Although it might not make a flashy sale on the spot, you never know where a networking opportunity may lead down the line.

Companies are Looking for Advancements in Braille Inspections

GlobalVision’s new braille inspection software gained the attention of many attendees at Drupa 2024. Since braille has become mandatory on all pharmaceutical products in Europe, braille inspections have posed challenges to the print and packaging industries. This includes slowing down efficiency in production and approvals processes, increasing subjectivity and human error in manual inspections, increasing cost due to slow inspection speed, limiting options for scalability and increasing compliance risks.

What we learned is that previous solutions for measuring braille height haven’t fully met the growing need for detailed braille height inspection – until now, with Detailed Braille Height Inspection. This product is 10x faster and more cost-effective than other braille solutions, along with other features that made it a hit at Drupa.

GlobalVision isn’t done yet! Take a look at where we are still headed in 2024. 

/by
,

Drupa 2024: 4 Key Learnings From Week 1

Date: May, 2024 | Category: Company | Author: Myka Luchuk

Week 1 of Drupa has not disappointed – from incredible booths, engaging presentations, innovative solutions, and high foot traffic, it’s clear that the future is bright for the print and packaging industry.  

One of our biggest highlights has been engaging with current and prospective customers, putting faces to names in the print and packaging industry. These organic, personal connections continue to be a key contributor to our success, highlighting our passion for our product and customer experience.    

Here are some of the key trends we have noted in week 1:

1. A Focus on Sustainability 

This encouraging trend is evident throughout Drupa, with many exhibitors showcasing their sustainable packaging and solutions. Some of this year’s keynote speakers, such as Calvin Lakhan, a specialist in the field of environmental resource management and economics from York University, and Mark Maslin, Professor of Earth System Science at UCL and the Natural History Museum of Denmark, have also chosen topics to shine a light on the importance of environmental responsibility. 

Read this blog post to learn more about sustainable packaging.

2. The Importance of Artwork Management Systems (AMS)

Creating streamlined artwork management processes has been a hot topic amongst exhibitors and attendees alike. AMS provides centralized control over all artwork across every stage of production, providing consistency in all branded elements such as colours, fonts, logos, and more. Why is this so important? Print and packaging companies want to maintain quality control, not just for product appearance, but also to enhance regulatory compliance, reduce risk, increase efficiency, and get to market faster. 

Curious about how GlobalVision can be a part of this process for your business? GlobalVision hosts integrations with Esko, automating proofing and quality control throughout the artwork and content management process. Visit our booth during week 2, located at hall 8B, booth C32 to find out more.

3. Efficiency in Print and Packaging Processes

Regardless of their size, a common goal amongst print and packaging companies we have spoken to is to find solutions for scaling up their business. As manufacturers look to increase their production volume, this has generated intrigue into tools for efficiency in print and packaging processes. This means fewer steps, seamless integrations, automation tools, and reduced errors in inspections. 

Learn more about how GlobalVision has helped companies such as Smurfit Kappa Group increase efficiency by reading this customer story.

4. Braille Height Measurement

Drupa attendees have been excited by GlobalVision’s Detailed Braille Height measurement and inspection technology, which offers unmatched accuracy and speed that was previously not seen for braille inspections. This will allow companies to address unreliable and inefficient manual verification processes, reducing risks of incorrect braille translations, tactile issues, spacing errors, and spelling mistakes, all of which cause compliance issues such as financial penalties, recalls, risk to consumer and patient safety and damage to a company’s reputation. 

The Detailed Braille Inspection software is an integration into GlobalVision’s market-leading quality inspection product, GVD. Learn more about GVD and how it combines GlobalVision’s most powerful inspection tools into one robust application, ensuring the accuracy of files as they move along the quality workflow. 

Learn more about GlobalVision’s new Detailed Braille Height inspection software. 

As we look ahead to the final week of Drupa, we are excited to build new insights and connections. 

Visiting Drupa next week? Book a personalized live demo with us to see how we can enhance your inspection processes. Find us in hall 8B, at booth C32!

/by
,

GlobalVision in Action: Where You Can Find Us in 2024

Date: May, 2024 | Category: Company | Author: Myka Luchuk

GlobalVision is coming to you! In 2024, GlobalVision is heading to trade shows and conferences across North America and the EU to connect with current and prospective customers. By visiting one of our booths, you’ll have the opportunity to receive personalized consultations about your team’s needs, meet our team of experts, and more.

Find out where you can find us: 

Drupa 2024

Düsseldorf, Germany 

May 28 – June 7 

In 2024, the international print industry will once again meet at Drupa, the world’s leading trade show for print technologies—after an 8-year hiatus. GlobalVision will showcase innovative quality inspection solutions while fostering valuable connections at the top printing technology event of the year. 

Find us in Hall 08B at stand #8BC32!

12th Pharma Packaging and Labeling Innovation Forum Boston

Boston, United States

June 13 – 14

Pharma Packaging and Labeling Innovation Forum is the industry’s leading event that provides an excellent sourcing platform for international manufacturers, professional buyers, and decision-makers in the plastics, printing, and packaging industries. GlobalVision will be featuring Verify, the industry’s fastest cloud-based proofreading software that ensures error-free content while maximizing team productivity.

Find us at booth E4!

EskoWorld 2024

Grapevine, Texas, United States

June 25 – 27

EskoWorld 2024 will gather partners and customers from around the globe, with more than 500 professionals from various industries coming together for an exciting and informative series of discussions exploring accomplishments, shared obstacles, industry trends, and best practices. Learn more about our Esko Integrations, and visit our booth for more information.

Find us at booth 30!

Pharma Packaging and Labeling Innovation Forum Munich

Munich, Germany 

September  9 – 10

Pharma Packaging and Labeling Innovation Forum Munich provides a platform to discuss industry challenges for material and design innovations, sustainability, branding, and active packaging in the pharmaceutical industry. As part of GlobalVision’s expansion into the EU, this event plays a key role in our commitment to fostering strong relationships and delivering innovative solutions to regulated industries in Europe.

More details on where you can find us will be available soon! 

Veeva R&D Summit

Boston, United States

September  9 – 10

Veeva provides the opportunity to connect, learn, and collaborate with peers across clinical, quality, manufacturing, regulatory, safety, and IT industries at Veeva R&D Summit. Learn more about the Verify & Veeva Vault Integration, and visit our booth for more information.

More details on where you can find us will be available soon! 

Labelexpo Americas 2024

Chicago, United States

September 10 – 12

Labelexpo Americas is the largest event for the label and packaging printing industry in the Americas. Join us there to meet our awesome team and learn more about our industry-leading print and packaging inspection tools.

Find us at booth 1621!

Already planning to attend one or some of these events? Let us know you’re coming! Contact us so we can arrange a time to meet with you.

/by
,

Automating Proofreading to Enhance Regulatory Compliance

Date: May, 2024 | Category: Proofreading | Author: Hashem Ali

In regulatory compliance, a manufacturing change or a health authority request marks the beginning of a meticulous process for your team. 

You’re tasked with assessing the impacts of the requests, submitting updates, and ensuring that all affected regions adhere to the new compliance standards. From planning and execution, to tracking each product you manage, it involves a keen awareness of many details and nuances. Overlooking any aspect could lead to delays or legal challenges, highlighting the critical role of regulatory compliance.

The challenge of maintaining regulatory compliance is magnified by the complexities of proofreading and document control. When you expand these operations globally, dealing with various regulatory bodies and health authorities, each with its own set of guidelines, languages, and submission requirements, the necessity for automated proofreading in the context of regulatory compliance becomes even more unmistakably clear.

Identifying Opportunities for Proofreading Optimization in Regulatory Compliance

When tracking regulatory compliance on your documents, opportunities for proofreading optimization pop up from the very beginning of the product development process. 

Be it during the early authoring stages, where cross-functional teams iterate collaboratively through multiple revisions; all the way downstream to the printed cartons, labels and leaflets that, once dispatched, leave your direct control and become critical risk points for compliance. Not forgetting any additional approvals and MLR requests for various messaging and promotional content created around your product.

This extensive process, covering various regulations, languages, channels, and teams, raises an essential question for anyone aiming to enhance regulatory compliance through automated proofreading: where to begin?

Start with the Low Hanging Fruit for Regulatory Compliance

We operate under the assumption that any external document, text, or file represents a potential exposure to non-compliance. Thus, prioritizing parts of the document creation process that pose the highest risk of errors and delays is the simplest to address and can significantly impact regulatory compliance efforts.

Mapping out your regulatory workflow’s common triggers and actions offers a high-level view, essential for identifying where automated proofreading can most effectively enhance regulatory compliance.

Leveraging Automated Proofreading Tools for Regulatory Compliance

Consider the scenario of a product-related change. Once the impact is assessed and relevant information is gathered, the pre-publishing stage becomes critical. This stage demands rigorous proofreading and revision control to prevent non-compliance related delays.

Here, introducing an automated proofreading tool like Verify can ensure that documents are meticulously inspected before release, significantly reducing the risk of non-compliance.

Implementing a fully validated and compliant web-based tool like Verify means that you can be up and running within weeks. Allowing you to ensure that all documents at that critical pre-publishing stage are thoroughly and efficiently inspected before they are released. 

That kind of risk reduction with ease of implementation is your low hanging fruit and your first step towards regulatory compliance automation. 

Defining Automation in the Context of Regulatory Compliance

Automation exists on a spectrum, where on one end (0% automation), you have a very manual process like proofreading, driven by your individual efforts as a user; and on the other end (100% automation) you have a fully completed outcome that you consume as a user. 

You don’t just go from manual to automated in a couple of steps, you undertake a journey to automate small parts of your process in order to leverage the power of automation over time.

So, in order to set the table for our needs, we need to draw some boundaries on how we are defining automation for the very specific case of proofreading. 

Let’s take a step back. When proofreading, you are essentially doing one simple thing: comparing what you are looking at to a source of truth. 

Sometimes that source of truth is explicit, like a QRD, SPL document, or medical dictionary; and sometimes that source of truth is your own brain, it is implicit, where you compare what you are seeing to your own knowledge of grammar (in the case of spell checking) or your experience in dealing with a specific person at the FDA who needs a particular document formatted in a specific manner.  

Either way, the exercise of proofreading here is the same, you reference what’s in front of you to one or more sources of truth. You might get multiple team members to do this, by setting up a review and approval process, adding time and costs to the process.

This is a tedious and time consuming task that has one true goal – finding errors. Errors that can cause real delays and costs that come as a result of non compliance. 

Despite best efforts, the FDA reports 14,000 recalls over the past decade, amounting to about 4 recalls a day, meaning we still have a ways to go on this front. Thankfully, GlobalVision has been in the business of finding errors for over 30 years, helping the world’s largest life sciences organizations reduce risk, automate processes and make proofreading more efficient. 

Key Metrics for Proofreading Efficiency in Regulatory Compliance

To further enhance regulatory compliance, consider the following three metrics when expanding that definition across your regulatory workflow: 

  • Reducing Revisions: Document Development Speed

The authoring process differs depending on where you are in the product life cycle. Early in the cycle, document revisions and content creation make for many changes. Later on in the cycle, the document crystallizes and changes should be flagged for review. This is true from your digital files all the way downstream to the printed material. When automating this process, measuring and reducing your total revision count is a good indicator of whether or not you’re on the right track. 

  • Speed to Market: Reduce Cognitive Load Through Modular Content

When your team has too much to look at, and too much to consider at once, the probability of error increases.  

When so much energy goes into the creation of approved documentation, be it for submission or marketing purposes, it makes sense to recycle and reuse that content across your organization. Your Document Management System should be set up for modular content. This will allow you to get to market faster by re-using approved text assets such as copyright statements, approved definitions and claims; as well as approved digital assets like logos and photos. 

Using modular content, you will free up mental bandwidth for your team to focus on newer projects and new content creation. 

Globalvision partners with leading DMS and AMS companies like Veeva and Esko to integrate seamlessly into your workflow combining the powers of modular content with automated proofreading for a higher speed to market. 

  • Facilitate Decision Making by Consolidating Proofreading

The tools you use need to reduce complexity, not increase it. The UI and workflow need to be clear and simple, so your team can quickly decide if a change is approved or rejected. The proofreading tool should highlight exactly what’s changed, allow you to report on it, save your files and inspection to one location and be accessible anywhere, anytime. 

Your proofreading activities should be consolidated in one place, so you can review more than just text, but also inspect your graphics, barcodes and braille elements.

Measure this by looking at the total inspection time for your documents before and after you implement a proofreading tool. If the amount of time spent proofreading is reduced, then you know that you’ve taken a firm step towards automation.  

Continuous Improvement in Regulatory Compliance

We know that proofreading is often a thankless task. One that, when done correctly, no one notices, and when done incorrectly, your customer notices. 

By strategically integrating automated proofreading tools like Verify and focusing on key performance metrics, you can significantly enhance regulatory compliance. The journey towards full automation requires continuous evaluation and adaptation, but starting with targeted solutions like Verify can demonstrate immediate benefits in maintaining regulatory compliance.

Take the next step and try it out for yourself! Compare your first set of documents in Verify and explore the value it can bring to your regulatory compliance team.   

/by
, ,

10 Reasons Top Pharma Companies Automate Proofreading with GlobalVision’s ‘Verify’ Platform

Date: May, 2024 | Category: Proofreading | Author: Amanda De Luca

In the highly regulated and complex world of pharmaceuticals, accuracy and precision are paramount. Even minor oversights or errors in labeling, packaging, or documentation can lead to significant consequences from regulatory non-compliance issues such as sanctions and recalls, to potentially compromising consumer and patient safety. 

To navigate these challenges, leading pharmaceutical companies are increasingly leveraging advanced technologies like GlobalVision’s Verify to automate the proofreading and quality inspections of their critical content and labeling files. 

In this blog post, we will explore 10 reasons why leading pharma companies are opting for automation with Verify and putting their trust in this market-leading software.

1. Ensures Regulatory Compliance

It’s no secret that health authorities such as the FDA in the United-States and the EMA in Europe  impose stringent regulations and  guidelines on pharmaceutical companies, making compliance a non-negotiable. 

These companies operate within an environment of strict regulatory guidelines and any deviation from these standards throughout the drug development and packaging process, can lead to regulatory sanctions  or even hefty fines—noting that this also applies to medical device companies.

Verify’s cloud-based automated proofreading tools  are designed to detect any potential deviations or errors in documentation from text, graphics, barcode and even braille, thus ensuring that documentation and all critical content align with regulatory requirements, minimizing the risk of non-compliance and associated penalties. Key features built into the platform such as medical and custom dictionaries are there to streamline the workflows of regulatory professionals, and ultimately providing peace of mind when it comes to compliance.

2. Eliminates Human Error

Manual proofreading and quality inspections are prone to human error, especially when dealing with large volumes  of documents which only increase with the size of the organization. Those tasked with this tedious process are often prone to fatigue due to long hours of reviewing text-heavy documents such as Instructions for Use (IFUs). This is where automated proofreading comes to play, setting out to eliminate the risk of human error in such processes. 

Verify’s cloud-based automated proofreading tools  significantly reduce the chances of oversights, ensuring that critical information is accurately reviewed and approved. As a result, the efficacy and accuracy of the proofreading process are drastically enhanced, offering a reliable solution for meticulous document scrutiny across pharmaceutical companies.

3. Accelerates Time-to-Market

Experts suggest that delaying the commercialization or launch of a $150 million pharmaceutical product by just one month could lead to a sales shortfall exceeding $12 million. This is why life sciences enterprises cannot depend solely on existing full-time employees engaged in other duties to facilitate a product launch.

Verify’s automated proofreading software streamlines the proofreading process, reducing the time required for quality control and enabling companies to bring products to market faster without compromising on quality or accuracy. 

By automating the proofreading process, Verify’s automated solution frees up valuable human resources within pharmaceutical companies allowing teams to focus on more strategic tasks, such as research and development, while the software aids in the meticulous task of quality control. 

Thanks to this automation, the regulatory, labeling, and commercial processes within pharma are significantly optimized, resulting in a swifter time-to-market, which is key for capturing market share and maintaining a competitive edge in the market. 

For perspective see what a top pharmaceutical company had to say about GlobalVision’s automated solutions, “Manually proofreading one document would take one hour to complete. Considering workloads of over 2 dozen document inspections weekly, manual checks would result in 24 hours of proofreading in a week. With GlobalVision, this task is completed within minutes.”

4. Helps with Brand Equity 

Precision is crucial in pharmaceutical documentation, however this does not only apply to text but to all components of a document as well. 

Pharmaceutical documentation often includes graphics such as logos, diagrams, and more. Automated proofreading, with its robust and comprehensive capabilities, is capable of inspecting these graphics for any discrepancies with pixel-to-pixel accuracy, ensuring that they meet quality standards and are correctly placed within the document without any errors. 

What’s more, this precise graphics compare capability enables companies to better ensure brand equity by checking graphical components such as logos and images. By checking these graphics, companies can ensure that all brand guidelines are being followed and met and that products are reaching consumers at the highest quality, ensuring brand reputation and subsequently, brand loyalty. 

With such precise and accurate graphics comparisons, pharmaceutical teams can be sure that not only is their text and spelling correct, but their artwork and complete product is accurate as well. 

5. Eases Global Scalability 

Pharma companies often operate globally and need to cater to diverse markets with different language requirements. 

Automated proofreading tools such as Verify supports multilingual proofreading and checks spelling in 37 global languages which includes Medical and Custom dictionaries to cater to the unique terms and needs of individual companies. What’s more, Verify is able to find discrepancies in different scripts and alphabets such as Asian characters, Cyrillic, Greek, etc. and can also accurately inspect right-to-left languages such as Arabic and Hebrew. 

This advanced capability not only aids in the enhanced accuracy of pharmaceutical products, it also makes scaling globally much easier for global enterprises with customers all over the world. In one quick inspection, companies can leverage the advanced language capabilities available to them in Verify and check for text and spelling differences, all within a seconds to minutes. 

This allows companies to maintain consistency and accuracy across various languages and regions and enables them to scale more easily, meeting the needs of their customers worldwide. 

6. Enhances Collaboration

Verify’s automated proofreading software facilitates collaboration among teams by providing a centralized platform for proofreading and quality inspections. This ensures that all stakeholders, from regulatory affairs to labeling and commercial teams, can review documents and share reports with relevant stakeholders, fostering better communication and alignment amongst teams and cross-functionally.

Also, the capacity to monitor modifications and uphold version control guarantees that every stakeholder has access to the latest information. This leads to better-informed choices and enhances the quality of documentation and subsequently, products. 

7. Minimizes Product Recalls

Product recalls can be detrimental to a pharmaceutical company’s reputation and finances. 

For perspective, clinically important drug recalls occur approximately once per month in the United States while one of the top recall causes in pharmaceuticals is incorrect labeling. 

Automated proofreading helps identify these potential issues early in the production process by pinpointing inconsistencies and deviations in critical documentation, allowing teams to catch errors on time and make the necessary adjustments before it’s too late. This enhances the accuracy and consistency of information, minimizing the risk of recalls due to documentation or labeling errors and safeguards both consumer safety and the company’s reputation.

8. Improves Cost Efficiency

Manual proofreading is not just time-consuming—it can also be expensive! 

Hiring external proofreaders, especially when dealing with languages where native speakers are needed for the task, or simply allocating internal resources for this task incurs costs that add up over time. While implementing automated proofreading solutions may require an initial investment, the long-term cost savings and return on investment are substantial. 

By reducing the need for manual proofreading and minimizing errors, Verify enhances cost efficiency in the pharmaceutical production process and is ultimately a solution that pays for itself through increased efficiency and error prevention.

9. Offers Comprehensive Reporting

For pharmaceutical companies, documentation is not just about producing critical documentation such as labels and inserts — it’s also about maintaining a detailed record of changes and approvals. 

Verify, with its automated proofreading features, provides comprehensive reporting tools that track every step of the proofreading process, offering transparency and audit trails for regulatory purposes. This not only helps in inspection and revision workflows it also is a key competent in ensuring data integrity. 

In fact, automated proofreading software is not just a form of error-detection software, GlobalVision’s Verify features an audit trail for compliance with FDA 21 CFR Part 11. The platform doesn’t just go over the document pixel-by-pixel or character-by-character to detect graphics and text differences, it also tracks parameter changes and log-ins, so data becomes “attributable,” one of the five principles of data integrity.

10. Adapts to Evolving Technologies

Verify prioritizes innovation and is constantly evolving through feature enhancements and regular updates. 

As technology continues to advance, pharmaceutical companies must stay ahead of the curve. Verify, as GlobalVision’s newest and most innovative cloud-based, automated proofreading tool, is a future-ready solution that adapts to evolving technologies, ensuring that pharma companies can meet the challenges of an ever-changing industry.

The software is updated every quarter and also leverages the newest technologies such as machine learning and artificial intelligence. By embracing these technologies, Verify equips pharmaceutical companies with the latest and most cutting-edge proofreading tools, constantly setting the bar higher with each new software release.

Automate Your Proofreading Today

For the pharmaceutical industry, the benefits of automating proofreading processes with GlobalVision’s Verify are evident for top pharma companies striving for excellence in quality control. 

From ensuring regulatory compliance to accelerating time-to-market, top pharma companies are choosing automation as a strategic investment in precision, efficiency, and overall operational excellence. 

As the pharmaceutical world continues to evolve, automation through proofreading software becomes not just a choice, but a necessity for success in a highly competitive and regulated environment.

Learn more about Verify’s automated proofreading solutions by booking a demo today.

/by
,

5 Tips To Get the Most Out of Drupa 2024

Date: May, 2024 | Category: Company | Author: Hana Trokic

Are you ready to join GlobalVision in creating the future of print technology at Drupa 2024? 

If you’re planning to attend the world’s leading trade fair for print technologies in Düsseldorf , Germany this year, you don’t want to miss out on all of its amazing opportunities for networking, learning, and business growth. A two-week long event, Drupa has a jam-packed program filled with keynote presentations, talks, and sessions covering everything you need to know about print. 

Drupa only happens once every four years so plan ahead to make sure you’re making the most out of it! Thankfully, GlobalVision has compiled a list of 5 top tips to make this year’s Drupa experience unforgettable.

1. Explore the Full Program

From May 28th to June 7th, Drupa will be offering a rich program including seminars, workshops, and special forums focusing on the latest Print industry trends. Everything from  print, packaging, labeling, graphic design, AI and innovative technologies in the printing industry will be covered to give attendees deep insights into current trends and the future of print technologies.

A Drupa 2024, attendees can listen to sessions in the following forums or touchpoints:

  • Drupa Cube: discover a pioneering conference program that presents the latest developments in the print and packaging industry.
  • Touchpoint Packaging: presents proven and innovative new concepts by leading experts from all areas of the value chain and offers the opportunity to explore the latest developments in packaging design and production.
  • Touchpoint Textile: dedicated to an innovative, fully connected production chain: from design to finished product in various forward-looking areas and business models of the textile industry.
  • DNA – Drupa Next Age: opens the doors to innovative ideas, pioneering technologies and up-and-coming talents. Experience how young talents and start-ups are revolutionizing the print industry.
  • Touchpoint Sustainability: this special forum communicates challenges, solutions and visions for more sustainability in the entire printing and paper industry in a transparent, company-independent and constructive manner.

This year has also announced some amazing keynote speakers from:

  • Vicky Pryce – a leading economist working on UK, global and Eurozone issues
  • Rory Sutherland – Vice Chairman at Ogilvy and one of the world’s most respected marketing thinkers
  • Mark Maslin – Professor of Earth System Science at UCL and the Natural History Museum of Denmark
  • James Loudon – Managing Partner at Asia Growth Partners and a seasoned business ecosystem developer and program builder
  • Calvin Lakhan – PhD at York University, Toronto and a specialist in the field of environmental resource management and economics 

Don’t Miss These Session 

With so much to do and see, unfortunately this means you won’t be able to attend all sessions at Drupa 2024. That being said, there are some you definitely do not want to skip. Keep an eye out for the following Keynote sessions:  

Rory Sutherland: There’s a reason we call it Cheap Talk – Print costs more than pixels – and that’s why it works so well!

    • Forum: Drupa Cube
    • Date: May 30th 2024 
    • Time: CET 10.45 – 11.45
    • Location: Hall 6  

Vicky Pryce: Global Economic Trends and What the Future Holds

    • Forum: Drupa Cube
    • Date: May 28th, 2024 
    • Time: CET 11.15 – 12.15
    • Location: Hall 6  

James Loudon: Hyper Local Still Global – Asia as a Source of Growth and Innovation

    • Forum: Drupa Cube
    • Date: June 4th, 2024 
    • Time: CET 10.45 – 11.45
    • Location: Hall 6  

Dr. Calvin Lakhan: Sustainability is Not a Universal Language

    • Forum: Drupa Cube
    • Date: June 6th, 2024 
    • Time: CET 10.45 – 11.45
    • Location: Hall 6  

The full Drupa 2024 program can be found here. 

Make sure to review the event schedule beforehand to plan your days effectively. This allows you to attend key presentations and still have time for networking and exploring the exhibition. 

2. Use the Networking Opportunities

Drupa is not only a prime event to expand your knowledge about the Print industry and its specific needs, it is also a prime networking event with thousands of industry professionals attending from all over the globe. 

Every single exhibitor will have networking opportunities at their booth while dedicated areas will be set up throughout the exhibition hall where attendees can sit, talk and exchange experiences while learning more about products and services that are helping shape the future of the Print industry.  

To better prepare yourself, make note of exhibitor booths you would like to visit and where their booths are located. 

You can find the entire Drupa hall plan here. 

Experience Drupa 2024 with GlobalVision 

GlobalVision is going to Drupa 2024 and we want to share this year’s experience with you! To show how excited we are, we’re offering special benefits for all Drupa attendees.  

Book a personalized demo to see firsthand how we are enhancing quality control in the Printing industry while taking advantage of our Drupa discount of up to 20% off your GlobalVision license. 

Demos can be booked for the following products, services, and capabilities: 

  • Print Inspection System (GVD)
  • Cloud PDF & Proof Inspection
  • Esko AE Tickets: Artwork, Barcode, Spell, Text 
  • Esko WebCenter Digital Inspection
  • Braille Height Inspection
  • Barcode Decode & Quality
  • Spell Check
  • Text Inspection
  • Counting System for Inserts, Cartons, Vials
  • Large-format Scanners for Full Press Sheet Inspection

Spaces are limited, so be sure to secure your spot by booking your demo today. Don’t miss the opportunity to get GlobalVision’s market-leading proofreading software at a discounted price. We will also be giving away two free GVD licenses for 6 months live at the event. Be sure to visit our booth, Stand #8BC32, Hall 08B, to take part in our draw and test your luck!

3. Dress the Part 

When dressing for Drupa 2024, it’s important to take into consideration the long hours of the daily programs as well as the fact that the event is 2 weeks long!  

Because of this, make sure to pack enough clothing to have in your Drupa rotation and make note to balance professionalism with comfort, considering the extensive walking and networking you will be doing on a daily basis. Opt for business casual attire that reflects professionalism yet allows for ease of movement around the large exhibition space. As the event is being held in the warmer months, choose natural, breathable fabrics that do not wrinkle easily to help you look your best. 

It is also important to think about your choice of footwear for Drupa 2024! #Drupashoes are a thing for a reason so be sure to wear comfortable, supportive shoes as you will likely be on your feet for long periods. Bring at least three pairs that you can rotate throughout the event, ranging from dress shoes to smart sneakers. This will help alleviate the stress on your feet and will keep you walking for miles throughout the exhibition hall. 

4. Pack the Daily Essentials 

With thousands of exhibitors showing their products and services you want to make sure you have the energy to see them all! 

Every day, before you head to the exhibition hall, be sure to pack some essentials that will help you get through the day. For starters, always make sure to have a water bottle on hand that you can fill up throughout the day to keep you hydrated. Also, be sure to pack some light snacks that are easy to carry like granola bars, crackers, or dried fruits and nuts – these will come in handy during the long days and will help satisfy your hunger in between meals.  

Some other practical things to pack include hand sanitizer – to ward off any germs that may come your way, and breath mints – to ensure your breath is fresh for every impromptu business-changing conversation you might have during the event.

5. Explore the City of Düsseldorf 

While the main focus of your trip might be the trade fair, taking some time to explore Düsseldorf and have some fun outside of the exhibition hall can really help enhance your experience! The city offers various cultural attractions, dining, and shopping options that are all ready to be discovered.

For a leisurely day, take a stroll along the Rheinuferpromenade, a scenic riverside walk that leads to the bustling Altstadt (Old Town), renowned for its traditional Altbier, a dark beer that’s brewed locally. Shopping lovers will find Königsallee, also known as “Kö,” ideal for luxury shopping or browsing. For those interested in architecture and panoramic views, the Rhine Tower offers an impressive outlook over the city and beyond. 

If you’re a coffee connoisseur or a foodie, don’t forget to stop by some of the local cafes or top restaurants for a caffeine kick or bite to eat while enjoying the social atmosphere of Düsseldorf.

See you at Drupa 2024

Drupa 2024 is quickly approaching and we can’t wait to see you there! Mark your calendars for May 28th to June 7th and join GlobalVision in Dusseldorf, Germany at the world’s leading trade fair for print technologies.

We can’t wait to meet you, showcase our products and solutions, and show how GlobalVision is creating the future of printing technology by empowering organizations to achieve excellence in quality control through mistake-free printing. 

See you at Drupa 2024!

/by
, ,

Reduce Your Carbon Footprint & Boost Sustainability Through Automated Proofreading

Date: April, 2024 | Category: Proofreading | Author: Hana Trokic

Automated Proofreading—A Sustainable Approach to Proofreading That Reduces Carbon Footprint in the European Union and Beyond 

The current global climate urges sustainability not just in individual aspects of our lives, but also in the ways we conduct business – from European Union (EU) markets and beyond.  

As individuals and businesses alike strive to reduce their carbon footprint, innovative solutions emerge to address this growing concern, one solution lies in automated proofreading—a tool that not only enhances the overall efficiency of workflows across various industries but also contributes to the sustainability efforts of global organizations.

The Environmental Impact of Traditional Proofreading Methods

Traditional manual proofreading methods involve printing documents on paper, manually reviewing them, and making corrections by hand. This approach is not only time-consuming but it is also resource intensive as vast amounts of paper are required to proofread documents while significant energy for printing and transportation is also needed.

Additionally, manual reviews are unreliable methods that are prone to human error, especially when dealing with complex documentation that includes small text, graphics, barcodes, and braille. This increases the risk of misprints and leads to resources being wasted for a single set of documents or packaging assets.  

Now, consider the cumulative effect of this process across industries and sectors worldwide, and the effect these manual methods have on the environment becomes evident. From forest depletion for paper production to emissions generated by transportation and disposal, traditional proofreading practices can significantly contribute to ecological degradation.

According to studies from Gartner, 50 percent of business waste is composed of paper products, with the average office worker going through 10,000 sheets of paper per year. These numbers alone are staggering and don’t even account for other print products such as boxes, labeling, and packaging. In the EU alone for example, from 2010 to 2021, paper and cardboard was the main packaging waste material (34.0 million tonnes in 2021), 

Looking further at the environmental implications, 40 percent of the world’s timber is being cut down for paper production, making the need for sustainability in business practices in the EU and globally even more apparent as brands and consumers alike should look for ways to limit this waste in resources. 

Automated Proofreading for Sustainability

Automated proofreading offers a sustainable alternative that aligns with modern technological advancements. By leveraging innovative technologies, automated proofreading software meticulously inspects documents for errors in text, graphics, barcode and braille, eliminating the need for manual reviews.

This digitalization not only leads to less physical resources, like paper, being used, it also increases accuracy in proofreading, lowering the risk of errors slipping through to print, resulting in less reprints and less waste in production. 

Specifically, automated proofreading technology plays a significant role in promoting sustainability across various industries in the EU through the following sustainability efforts.

Paper Reduction

Automated proofreading eliminates the need for printing documents for proofreading purposes. By inspecting digital files directly, it drastically reduces paper consumption. This reduction in paper usage not only conserves valuable natural resources but also minimizes the environmental impact associated with paper production, transportation, and disposal.

Energy Conservation

Additionally, traditional proofreading methods involving printing and manual reviews consume substantial amounts of energy. By automating the proofreading process, automated proofreading software reduces the energy consumption associated with printing equipment and related machinery. This conservation of energy contributes to lower carbon emissions and supports EU business efforts in creating more sustainable and environmentally friendly processes. 

Waste Reduction

Manual proofreading often results in discarded or outdated printed materials, contributing to waste generation. With automated proofreading software, errors are identified and corrected digitally, eliminating the need for physical copies and reducing waste. 

It is also important to note that the software finds errors in the early stages of asset development, mitigating the risk of errors slipping through in the final phases of production and print. This helps prevent misprints from occurring and significantly reduces waste production, increasing the sustainability of EU business practices and processes.  

Enhanced Accuracy

Automated proofreading software offers unparalleled accuracy in error detection and correction. By leveraging the latest and most advanced technologies such as artificial intelligence, this software identifies even the smallest errors that are likely to be overlooked manually. This high level of accuracy reduces the need for reprints and revisions, further minimizing resource consumption and waste generation.

Streamlined Workflows

Automated proofreading software streamlines workflows by automating repetitive tasks and accelerating the identification of errors. This efficiency improvement not only saves time and resources but also enhances overall productivity. By optimizing workflows, the technology enables organizations in the EU to accomplish more with fewer resources, ultimately promoting sustainability through resource efficiency.

Remote Collaboration

Automated proofreading facilitates remote collaboration by enabling users to proofread documents digitally from any location. This capability reduces the need for physical meetings and transportation, thereby lowering carbon emissions associated with travel. By promoting remote work and collaboration, the technology supports sustainable practices by minimizing environmental impact.

Increased Sustainability with GlobalVision’s Suite of Automated Proofreading & Quality Inspection Tools

As we continue to strive to reduce our carbon footprint and increase sustainability, adopting automated proofreading technology represents a meaningful step in the right direction. 

More specifically, GlobalVision’s suite of automated proofreading and quality inspection tools are the ideal solution for promoting sustainability within various regulated industries as it is not only tailored to meet the stringent standards of regulated industries, it also streamlines revision workflows to reduce the unnecessary use of resources and energy. 

GlobalVision’s Verify 

For pharmaceuticals, CPG, and agencies in the EU, GlobalVision’s Verify is a cloud-based automated proofreading solution that can help increase sustainability within regulatory compliance, labeling quality control, and promotional materials quality control. 

By digitizing the document and packaging asset review process, the platform minimizes paper and energy consumption throughout the asset development life cycle. Organizations in the EU will be able to use less paper and energy throughout the regulatory, labeling, and promotional stages.  

GlobalVision Desktop 

For print and packaging companies in the EU, as well as incoming quality assurance within brands, GlobalVision Desktop helps sustainability in processes pertaining to press quality control and production quality control 

Built for use in production and incoming quality environments, GlobalVision Desktop combines powerful inspection tools into one robust application and ensures files are accurate as they move along the quality workflow. Due to its precision and accuracy, the platform minimizes errors that lead to production waste. It also minimizes document versions and decreases revision times leading to a significant reduction of paper and energy use across the production lifecycle and increases sustainability of workflows.  

Conclusion

Striving to become more sustainable in your everyday processes whether big or small—matters. 

Automated proofreading represents a tangible and impactful way for organizations in the EU and beyond to reduce their carbon footprint and increase sustainability while optimizing productivity and accuracy. 

Not only will it enhance operational efficiency but it will also significantly reduce resource consumption and waste generation. By leveraging advanced technologies, such as Verify, businesses can streamline revision workflows, minimize paper and energy use, and ensure the accuracy of critical documents from the very beginning of the production lifecycle.

Overall, automated proofreading not only contributes to individual businesses’ sustainability goals but also advances collective efforts towards a greener, more sustainable future for all.Request a demo of Verify’s automated proofreading software today and see how this technology can revolutionize your every day, sustainable business practices.

/by
, , ,

A Guide to EU Pharma Regulatory Compliance: Everything You Need to Know

Date: April, 2024 | Category: Compliance | Author: Hana Trokic

Understanding the complex regulatory compliance landscape of the European Union’s (EU) pharmaceutical industry poses a significant challenge for companies aiming to remain compliant while ensuring the highest standards of product quality and safety. 

The stringent regulatory framework for EU pharma, designed to safeguard public health, mandates adherence to rigorous regulatory compliance with the European Medicines Agency (EMA),  Heads of Medicines Agencies (HMAs), the European Commission, and guidelines such as the Good Manufacturing Practice (GMP), and the Good Clinical Practice (GCP), among other requirements. 

By exploring the pivotal role of technology in enhancing compliance, and highlighting the importance of quality control systems like automated proofreading technology, this guide serves as a roadmap for pharmaceutical companies striving to navigate the demanding regulatory environment of the EU. 

Understanding EU Pharmaceutical Regulatory Compliance

The foundation of staying compliant begins with a thorough understanding of the relevant regulations in the European Union. 

The EU has established a comprehensive regulatory compliance framework that includes directives and regulations from the above-mentioned health authorities, along with specific national regulations of member states.

All of these guidelines are in place to ensure the safety, efficacy, and quality of pharmaceutical products, subsequently ensuring their proper use and the well-being of consumers and patients. These guidelines cover a broad spectrum, from clinical trials to marketing authorizations, pharmacovigilance, and manufacturing practices. 

Key EU Pharmaceutical Guidelines

Key pharmaceutical guidelines for the EU are enforced by the European Medicines Agency (EMA) and national regulatory agencies within member states, aiming to harmonize regulatory compliance standards across the EU and ensure the highest level of protection for public health.

Some key guidelines include: 

  • Good Manufacturing Practice (GMP): Any manufacturer of medicine intended for the EU market, regardless of its global location, must adhere to GMP standards, ensuring that the medicines are of consistently high quality, appropriate for their intended use, and meet the requirements of the marketing authorisation or clinical trial authorisation.
  • Good Clinical Practice (GCP): Represents an ethical and scientific quality benchmark for the design, recording, and reporting of trials involving human subjects, ensuring public confidence by protecting the rights, safety, and wellbeing of participants and guaranteeing the credibility of clinical trial data.
  • Good Laboratory Practice (GLP): Defines a set of rules and criteria for a quality system focused on the organizational process and conditions under which non-clinical health and environmental safety studies are systematically planned, executed, monitored, documented, reported, and archived.
  • Good Distribution Practice (GDP): Ensures that medicines are legally authorized, correctly stored and transported, free from contamination, properly rotated in storage, and delivered on time to the right recipient. It also mandates a tracing system for identifying and recalling faulty products. Additionally, GDP covers the proper handling of active ingredients and other materials used in making medicines.
  • Clinical Trials Regulation (EU) 536/2014: Aims to unify clinical trial rules across the EU by introducing a single submission and authorization process through an EU portal, a uniform assessment leading to one decision, and clear rules on participant protection, informed consent, and transparency.
  • Pharmacovigilance Legislation: Enacted in July 2012, this legislation mandates reporting and monitoring of adverse effects from medical products to ensure patient safety. It also establishes regulatory frameworks for assessing risks, managing safety information, and communicating it to healthcare professionals and the public.
  • Advanced Therapy Medicinal Products (ATMPs): ATMPs are divided into three main categories:
    • Gene therapy medicines: includes genes that cause therapeutic, preventive, or diagnostic effects by introducing lab-created DNA into the body to treat diseases like genetic disorders, cancer, or chronic illnesses.
    • Somatic-cell therapy medicines: consist of cells or tissues that have been altered in their biological characteristics or are used in different ways from their original functions in the body, aiming to treat, diagnose, or prevent diseases.
    • Tissue-engineered medicines: involve cells or tissues modified to repair, regenerate, or replace human tissue.

Leveraging Technology for Regulatory Compliance

Having gone through key pharmaceutical regulations in the European Union, let’s explore how technology helps organizations adhere to them to ensure the regulatory compliance of their products. To do this, technology plays a critical role in achieving and maintaining compliance, especially in regulated industries such as pharmaceuticals. 

Automated systems and advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) are being leveraged to streamline regulatory compliance processes throughout the pharmaceutical and drug development lifecycle. These algorithms analyze vast amounts of data to identify patterns, deviations, and potential risks in manufacturing processes, enabling proactive intervention to prevent compliance breaches. 

For perspective, GlobalVision’s independent market research has recently shown that AI-powered technologies help pharmaceutical companies get their products to market faster. Our survey results revealed that 89% of regulatory survey respondents said that using AI-powered solutions significantly reduced their compliance review process, allowing them to deliver products to market faster.

This goes hand in hand with recent plans being put into place with regards to the use of AI in EU pharma. As it is predicted to be so substantial in the near future, the EMA and the HMA have published an artificial intelligence work plan to 2028, setting out a collaborative and coordinated strategy to maximize the benefits of AI to stakeholders while managing the risks.

Along with AI technologies, other solutions to consider are quality control systems that help organizations stay compliant by easing the regulatory compliance process, and improving processes, and also cloud-based solutions that enable data sharing among stakeholders to maintain data integrity and confidentiality. 

It is also important to take into consideration solutions that have gone through a validation process. Validation involves a series of activities that take place over the lifecycle of any product and process to ensure that it has the required quality and is satisfying all requirements before being used. 

By integrating these technologies into regulatory compliance frameworks, and taking into consideration certain features, EU pharmaceutical companies can enhance regulatory compliance, minimize risks, and ultimately improve the quality of their products.

The Right Solution for Regulatory Compliance – Automated Proofreading Software

Choosing the right technological solution is essential for ensuring compliance with EU regulations. But one that incorporates many solutions and leverages many technologies may be the best way to go. This is where automated proofreading software comes into play. 

Automated proofreading is an innovative quality control solution for pharmaceuticals that helps  maintain the accuracy and quality of documents and subsequent products by inspecting all types of regulatory content present in pharmaceuticals. 

These documents include, packaging inserts and leaflets, product labels and packaging, regulatory submissions, clinical trial protocols and reports, Standard Operating Procedures (SOPs), and marketing materials such as brochures, websites, and promotional videos.

Regardless of the type of file or document, the advanced system helps pharmaceutical companies in the EU uphold quality standards with greater ease and efficiency, ensuring regulatory compliance within the EU.

This technological innovation provides better proofreading results and empowers teams to produce compliant and error-free documents as it acts as an added layer of insurance in quality control processes. Some benefits of automated proofreading include:

  • Proofreads critical content at scale: Automates proofreading of large volumes of documents at lightning speed, saves valuable time and resources and accelerates company growth while maintaining quality assurance.
  • Mitigates risk of financial losses: Automatically identifies critical errors such as incorrect drug names, dosages, and safety warnings and minimizes the risk of costly errors like product recalls, legal disputes, regulatory fines, reputational damage.
  • Expedite time-to-market: Increases speed of review and approval cycles for regulatory submissions, labeling, packaging, marketing materials and more and allows organizations to gain a competitive market advantage.

In essence, automated proofreading works by comprehensively inspecting documents to find discrepancies in the file. The innovative software conducts detailed inspections and proofreads all packaging assets from text, color, graphics, barcodes, braille, and more. 

Through automated proofreading, inspections of packaging components are completed exponentially faster than traditional proofreading, and a task that once took hours or days to complete is now reduced to only a few minutes.

“The biggest benefit [of GlobalVision] to our facility is the reduction in the amount of processing and testing time (by at least a factor of 3) and the ability to receive competent and timely support when needed….Overall, the greatest benefit is being able to rely on a high-quality product that allows us to be more efficient.”

  • Veronica Guilliams, Senior Manager – Visual Inspection, Pfizer 

Why Automated Proofreading is Essential for EU Regulatory Compliance 

Automated proofreading software plays a crucial role in enhancing the quality and regulatory compliance of pharmaceutical products in the EU. Some reasons why automated proofreading is an essential tool and software to leverage are:

  • Error Detection: Swiftly identify potential errors on pharmaceutical files, guaranteeing both accuracy and quality. This is vital not only for regulatory adherence but also for safeguarding patient safety. Accurate content ensures vital product information such as ingredients, dosages, and expiry dates are correctly portrayed, mitigating potential risks and upholding user well-being.
  • Consistency: Verify consistency in terminology, dosage information, and instructions throughout pharmaceutical documentation. Consistent information reduces confusion among healthcare professionals and users, enhancing clarity and usability.
  • Regulatory Compliance: Adhering to stringent regulatory requirements is critical in the pharmaceutical industry. Automated proofreading ensures all content aligns with regulatory standards, minimizing the risk of non-compliance issues such as fines, recalls, or legal repercussions.
  • Efficiency and Speed: Streamlines the proofreading process compared to manual reviews and methods, offering significant efficiency gains. This speed offers a particular advantage in the dynamic and fast-paced pharmaceutical industry, where timely and accurate product releases are crucial to get oftentimes life-saving pharmaceuticals to market and to capture significant market share. 
  • Version Control: Facilitate effective version control, ensuring that all documents reflect the most current and accurate information. This mitigates risks associated with outdated content, maintaining precision and relevance.
  • Consistent Branding: For pharmaceutical companies with diverse product portfolios, maintaining consistent branding across all products and content is essential for brand recognition and trust. Automated proofreading aids in upholding this consistency, reinforcing brand integrity.

By leveraging automated proofreading, EU pharmaceutical companies can elevate the accuracy, quality, and regulatory compliance of their products. This ultimately not only enhances patient safety but also preserves the integrity of medical products, aligning with corporations commitment to excellence and safety in healthcare.

GlobalVision’s Verify For Complete EU Regulatory Compliance

Verify, is GlobalVision’s cloud-based proofreading platform that is tailored specifically for the needs of regulated industries in the European Union such as pharma. 

The software has been meticulously evaluated and its functionality, performance, security, and compliance with relevant standards and regulations in the EU is guaranteed as the software fits the needs of end-users and helps adhere to industry-specific regulatory compliance requirements.

As a solution created for regulatory professionals, teams, and corporations, Verify seamlessly integrates with existing workflows and acts as an added layer of insurance that mitigates the risk of errors slipping through in highly-regulated documentation. 

The software allows for comprehensive inspections with robust capabilities including text and graphics comparisons, spell check, braille, and barcode inspections, all critical components of EU pharmaceutical documentation. What’s more, these comprehensive inspections are done in record-time and eliminate the need for tedious, manual reviews.  

This speed and precision in document inspections allow for faster review and approval cycles, enabling EU-compliant products to reach the market quickly, subsequently capturing market share from competitors due to their expedited workflows and allowing for a competitive advantage. 

Conclusion

For the pharmaceutical industry, navigating the complex regulatory landscape of the European Union is no easy task and demands commitment to compliance. 

The strict regulations set forth by governing health authorities in the EU are in place to help ensure the safety and efficacy of medicinal products while subsequently ensuring the safety of the end user. 

Once a tedious and time-consuming task, adhering to regulations becomes easier when corporations turn to technology to help them adhere to regulatory compliance 

Leveraging technology not only increases the speed at which quality control processes can be undergone, but also increases the accuracy and efficiency. Automated proofreading in particular, stands out as an ideal technological solution for EU pharmaceutical companies, offering advantages to document reviews such as error detection, speed, consistency, and version control, to name a few.

By integrating this technology, companies can not only meet EU regulatory compliance requirements but also uphold the highest standards of product quality and safety, thereby reinforcing their commitment to excellence in healthcare and ensuring the well-being of consumers and patients alike.

If you want to begin ensuring the regulatory compliance of your EU pharma documentation, book a demo of Verify and see firsthand the transformative impact it will have on your pharmaceutical proofreading and quality control processes.

Also, read our Pharmaceutical Industry Report to get exclusive insights into the growing role of technology in regulatory affairs and see how other top industry leaders are leveraging this technology to help them achieve their business goals. 

/by